rs397517034

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The NM_004985.5(KRAS):​c.-160_-158dupAGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 250,204 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 0 hom. )

Consequence

KRAS
NM_004985.5 5_prime_UTR

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.294

Publications

0 publications found
Variant links:
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
KRAS Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Noonan syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • linear nevus sebaceous syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 12-25250896-C-CGCT is Benign according to our data. Variant chr12-25250896-C-CGCT is described in ClinVar as Likely_benign. ClinVar VariationId is 45111.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00241 (366/152074) while in subpopulation AFR AF = 0.00838 (348/41534). AF 95% confidence interval is 0.00765. There are 2 homozygotes in GnomAd4. There are 172 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 366 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRASNM_004985.5 linkc.-160_-158dupAGC 5_prime_UTR_variant Exon 1 of 5 ENST00000311936.8 NP_004976.2 P01116-2A0A024RAV5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRASENST00000311936.8 linkc.-160_-158dupAGC 5_prime_UTR_variant Exon 1 of 5 1 NM_004985.5 ENSP00000308495.3 P01116-2

Frequencies

GnomAD3 genomes
AF:
0.00240
AC:
365
AN:
151966
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00835
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000721
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00192
GnomAD4 exome
AF:
0.000448
AC:
44
AN:
98130
Hom.:
0
Cov.:
0
AF XY:
0.000474
AC XY:
25
AN XY:
52784
show subpopulations
African (AFR)
AF:
0.0115
AC:
37
AN:
3216
American (AMR)
AF:
0.00
AC:
0
AN:
2110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4288
East Asian (EAS)
AF:
0.0000931
AC:
1
AN:
10738
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4132
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1470
Middle Eastern (MID)
AF:
0.00193
AC:
1
AN:
518
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
64858
Other (OTH)
AF:
0.000735
AC:
5
AN:
6800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00241
AC:
366
AN:
152074
Hom.:
2
Cov.:
32
AF XY:
0.00231
AC XY:
172
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.00838
AC:
348
AN:
41534
American (AMR)
AF:
0.000720
AC:
11
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10566
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67920
Other (OTH)
AF:
0.00190
AC:
4
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00202
Hom.:
0
Bravo
AF:
0.00291
Asia WGS
AF:
0.000294
AC:
1
AN:
3416

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Aug 12, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

-160_-158dupAGC in KRAS 5' UTR: This variant has not been previously reported in the literature or been identified in our laboratory. The 5' UTR plays a role in the regulation of gene expression and variants in this region have been shown t o alter protein translation (Mendell 2001, Scheper 2007). This type of variant h as not been previously reported in an individual with a Noonan spectrum disorder . -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.29
Mutation Taster
=299/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397517034; hg19: chr12-25403830; API